Evidence map›Paper›PMID 40813234›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Lymphoma Therapy Response Assessment with Low-Dose [

Clemens Mingels, Kevin J Chung, Hande Nalbant, Yasser G Abdelhafez, Naseem S Esteghamat, Mehrad Rokni, Shervin Zoghi, Joseph M Tuscano, Axel Rominger, Ramsey D Badawi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cardiovascular imaging with total-body PET.The British journal of radiology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Clemens MingelsDepartment of Radiology, University of California Davis, Sacramento, California; clemens.mingels@insel.ch.
Kevin J ChungDepartment of Radiology, University of California Davis, Sacramento, California.
Hande NalbantDepartment of Radiology, University of California Davis, Sacramento, California.
Yasser G AbdelhafezDepartment of Radiology, University of California Davis, Sacramento, California.
Naseem S EsteghamatDivision of Malignant Hematology, Cellular Therapy and Transplantation, Department of Internal Medicine, University of California Davis, Sacramento, California; and.
Mehrad RokniDepartment of Radiology, University of California Davis, Sacramento, California.
Shervin ZoghiDepartment of Radiology, University of California Davis, Sacramento, California.
Joseph M TuscanoDivision of Malignant Hematology, Cellular Therapy and Transplantation, Department of Internal Medicine, University of California Davis, Sacramento, California; and.
Axel RomingerDepartment of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Ramsey D BadawiDepartment of Radiology, University of California Davis, Sacramento, California.
Benjamin A SpencerDepartment of Radiology, University of California Davis, Sacramento, California.
Lorenzo NardoDepartment of Radiology, University of California Davis, Sacramento, California.

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI KC KENT LLOYD · 2002 to 2026
$84.9M
Basic applications for total-body PET in oncologyR01CA249422 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BADAWI, RAMSEY D., NARDO, LORENZO · 2019 to 2023
$3.1M
NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA249422
6 · The paper itself

Abstract

The improved sensitivity of total-body (TB) PET/CT offers the possibility of reducing injected activities. The aim of our study was to define a lower limit of reduced injected activities in [

Indexed as

Fluorodeoxyglucose F18LymphomaPositron Emission Tomography Computed TomographyRadiation DosageWhole Body ImagingAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedTreatment OutcomeFluorodeoxyglucose F18[18F]FDGDeauville scorelow-doselymphomatotal-body PET

Identifiers

PMID40813234
PMCPMC12410293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.